Coordinatore | AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Organization address
address: CALLE SERRANO 117 contact info |
Nazionalità Coordinatore | Spain [ES] |
Sito del progetto | http://www.mindview.i3m.upv.es/ |
Totale costo | 6˙991˙289 € |
EC contributo | 5˙381˙872 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2013-INNOVATION-1 |
Funding Scheme | CP-FP |
Anno di inizio | 2013 |
Periodo (anno-mese-giorno) | 2013-09-01 - 2017-08-31 |
# | ||||
---|---|---|---|---|
1 |
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Organization address
address: CALLE SERRANO 117 contact info |
ES (MADRID) | coordinator | 597˙487.00 |
2 |
GENERAL EQUIPMENT FOR MEDICAL IMAGING SA
Organization address
address: CAMINO DE VERA S/N EDIFICIO 9 B CIUDAD POLITECNICA DE LA INNOVACION contact info |
ES (VALENCIA) | participant | 1˙949˙980.00 |
3 |
UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
SE (UPPSALA) | participant | 536˙000.00 |
4 |
SENSL TECHNOLOGIES LIMITED
Organization address
address: BUILDING 6800 AVENUE 6000 CORK AIRPORT BUSINESS PARK contact info |
IE (CORK) | participant | 483˙800.00 |
5 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 468˙784.00 |
6 |
BENCAR AB
Organization address
address: DAG HAMMARKJOLD VAG 52B contact info |
SE (UPPSALA) | participant | 417˙300.00 |
7 |
NORAS MRI PRODUCTS GMBH
Organization address
address: LEIBNIZSTRASSE 4 contact info |
DE (HOCHBERG) | participant | 331˙820.00 |
8 |
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Organization address
address: ISMANINGER STRASSE 22 contact info |
DE (MUENCHEN) | participant | 324˙200.00 |
9 |
UNIVERSITE DE BRETAGNE OCCIDENTALE
Organization address
address: RUE DES ARCHIVES 3 contact info |
FR (BREST CEDEX 3) | participant | 136˙251.00 |
10 |
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Organization address
address: Piazzale Aldo Moro 5 contact info |
IT (ROMA) | participant | 136˙250.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The key concept behind this proposal is the development of a very high resolution and high efficiency brain dedicated Positron Emission Tomograph (PET) imager that can visualize neurotransmitter pathways and their disruptions in the quest to better diagnose and consequently to better treat schizophrenia. In addition, the plan is for this compact PET imager to be integrated with a Magnetic Resonance Imager Radio Frequency (MRI RF) system to be able to operate as a brain insert in a hybrid imaging setup with practically any MRI scanner. From the technical point of view, we propose to optimize the PET technology for imaging of the human brain with the accuracy typically achieved for small animal brain imaging. To achieve this, we will incorporate the solid state based MRI-compatible PET modules that will be designed to achieve below systemic 1mm spatial resolution in a tomographic reconstruction of the human brain. We aim to achieve the level of PET-MRI compatibility allowing for simultaneous PET and MRI imaging. By combining PET measurements of neurotransmission with fMRI (functional MRI) measurements of Blood Oxygen Level Detection (BOLD) signal changes we will advance to a position where it is possible to learn more about the neurochemical determination of neural activity reflected in BOLD signal changes. The novelty is that both the PET and RF coil systems are integrated into a portable and compact design dedicated to brain examination. This will allow current MR equipment to be easily upgraded into PET/MR systems. To achieve its diagnostic goal, MINDView will be paired with the set of dedicated specific PET imaging agents and endogenous compounds that will be labeled with short-lived positron isotopes. The goal is that dopaminergic, glutamatergic and other pathways will be able to be studied with the new high performance imaging tool. Innovative paradigms such as activation and perturbation and their impact on brain function will be in focus.'